Abstract:BACKGROUND:Membranous nephropathy (MN) is mainly classified into idiopathic MN (iMN) and secondary MN in etiology. In recent years, a new kind of membranous nephropathy, atypical membranous nephropathy (aMN) which shows "full house" in immunofluorescence but without definite etiology was paid more attention. In a single center cohort, the renal outcomes of iMN and aMN were compared. METHODS:iMN and aMN patients were selected from renal pathology databank from January 2006 to December 2015. Patients' demographics, laboratory values, induction regimens and patients' responses were recorded. Specially, creatinine, eGFR, albumin and 24 h urinary protein excretion were recorded at 6th month after the induction of immunosuppressive (IS) treatment and at the end of follow up. Complete proteinuria remission was defined as urinary protein < 0.3 g/d, partial proteinuria remission was defined as urinary protein between 0.3 g/d ~ 3.5 g/d and decreased > 50 % from the baseline. The primary outcome was worsening renal function, defined as a 30 % or more decrease in eGFR or end-stage renal disease (eGFR < 15ml/min/1.73m2). COX proportional hazard models were used to test if aMN was a risk factor of worsening renal function compared with iMN. RESULTS:There were 298 patients diagnosed with MN and followed in our center for 1 year or more, including 145 iMN patients with an average follow-up time of 4.5 ± 2.6 years, and 153 aMN patients with 4.1 ± 2.0 years (p = 0.109). The average age of iMN patients was older than aMN patients (56.1 ± 12.2 versus 47.2 ± 16.2 years old, p < 0.001). There were 99 iMN patients and 105 aMN patients with nephrotic range proteinuria and without previous immunosuppressive treatment. 93 (93.9 %) and 95 (90.5 %) patients underwent immunosuppressive treatment in iMN and aMN group, and there was no significant difference of the overall proteinuria remission rates at 6th month (59.1 % vs. 52.0 %, p = 0.334) and endpoint (73.7 % vs. 69.5 %, p = 0.505) between the two groups. 25 (25.3 %) patients in iMN group and 21 (20.0 %) patients in aMN group reached primary endpoint (X2 = 0.056, p = 0.812). Multivariate COX regression showed that after demographics, baseline laboratory values and remission status at 6th month were adjusted, aMN group had similar renal outcome compared with iMN group, the HR of primary outcome was 0.735 (95 % CI 0.360 ~ 1.503, p = 0.399). CONCLUSIONS:The proteinuria remission rates and renal outcomes were similar in iMN and aMN patients after covariables were adjusted.

Idiopathic membranous nephropathy in patients with diabetes mellitus: a diagnostic and therapeutic quandary!

New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy.

Membranous Nephropathy: Pathogenesis and Treatments

Idiopathic Membranous Nephropathy and Treatment Related Complications

Clinical and Pathology Features of Idiopathic Membranous Nephropathy Accompanied by Mesangial Dense Deposit

Non-diabetic urine glucose in idiopathic membranous nephropathy

Membranous Nephropathy Occurring with Type 2 Diabetes Mellitus .

Diabetic with Nephrotic Syndrome: A Case of "Masked" Membranous Nephropathy - A Case Report

Renal Outcomes of Idiopathic and Atypical Membranous Nephropathy in Adult Chinese Patients: a Single Center Retrospective Cohort Study.

Effects of Steroids-Free Immunosuppressive Treatment for Membranous Nephropathy Combining with Type 2 Diabetes Mellitus

Antiphospholipid Antibodies in Patients with Membranous Nephropathy.

Overlap of Primary Membranous Nephropathy, IgA Nephropathy, and Diabetic Nephropathy: A Case Report

The Combination Therapy of Glucocorticoids, Tacrolimus, and Mycophenolate Mofetil in Primary Membranous Nephropathy Coexisting with Type 2 Diabetes Mellitus: A Retrospective Study

The Application of Podocyte Antigen PLA2R and Anti-Pla2r Antibody in the Diagnosis and Treatment of Membranous Nephropathy

Clinical and Pathological Features of Idiopathic Membranous Nephropathy in Young Adults and Analysis of Outcomes

Progress on idiopathic membranous nephropathy

Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage

Membranous nephropathy: Mechanistic insights and therapeutic perspectives

Advances in Membranous Nephropathy

Clinicopathologicai Features and Prognosis of Idiopathic Membranous Nephropathy in Adults

Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome